Opening of Sartorius Stedim Biotech's new Shanghai validation lab.
Opening of Sartorius Stedim Biotech’s new Shanghai validation lab.

Sartorius Stedim Biotech (SSB) held a ribbon-cutting ceremony for their new facility in Shanghai on Wednesday. The laboratory at Shanghai Zhangjiang Hi-Tech Park will offer on-site validation services for membrane filters, as well as technical expertise. Together with SSB’s Application Center in Shanghai, the company provides a full range of extended services to the biopharmaceutical industry.

“Our Shanghai validation lab provides high-quality services that are fully compliant with applicable GMP and GLP principles,” stated Dr. Jörg Lindenblatt, SSB’s senior vp of sales for bioprocess solutions in Asia, in his opening speech. “At this validation service lab, we now offer comprehensive process validation studies for the strongly growing Chinese pharma market.”

The new Shanghai lab covers approximately 4,000 square feet. Equipped with the latest instrumentation, it offers microbiological testing services and physical-chemical testing to provide a full range of data for process validation studies in compliance with all regulatory requirements. Certified according to Biosafety Level II (BSL-2), the facility is permitted to handle specific critical bacteria and customer products.

Previous articleBiogen Hemophilia Spinoff Bioverativ Begins Trading Shares
Next articleCureVac Prostate Cancer Vaccine Candidate Fails Phase IIb Trial